The Latest Hyaluronic Acid Industry Statistics Explained
The global hyaluronic acid market size was valued at $1.05 billion in 2021.
The statistic indicates that in 2021, the global market for hyaluronic acid reached a value of $1.05 billion. This value represents the total revenue generated by the sales of hyaluronic acid products worldwide within that year. Hyaluronic acid is a popular ingredient in skincare, pharmaceutical, and medical products due to its moisturizing and anti-inflammatory properties. The market size figure provides insight into the economic importance and growth potential of the hyaluronic acid industry and can be used by businesses, investors, and policymakers to understand the market trends and make informed decisions.
The industry is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2022 to 2028.
This statistic indicates that the industry in question is forecasted to experience consistent growth over the six-year period from 2022 to 2028, with the compound annual growth rate (CAGR) projected to be 8.3%. This means that on average, the industry’s size or performance is anticipated to increase by 8.3% each year over the specified period. A CAGR takes into account the compounding effect of growth over time, providing a more accurate reflection of the industry’s overall expansion trajectory. The forecasted growth rate suggests a positive outlook for the industry, indicating opportunities for businesses within the sector to capitalize on the projected expansion and potentially achieve higher revenues and market share.
North America accounted for the largest revenue share of 48% in 2021 and is expected to witness considerable growth over the forecast period.
The statistic indicates that North America held the highest proportion of revenue, amounting to 48% of the total revenue in 2021 within the specific industry or market being discussed. This suggests that North America was the leading region in terms of generating income within the given context. Furthermore, the statement implies that there is an anticipation of significant growth in revenue for North America in the upcoming forecast period. This growth is likely due to various factors such as market trends, consumer behavior, economic conditions, and possibly strategic business initiatives in the region, positioning North America for further revenue expansion in the foreseeable future.
By product form, the single-injection cycle segment held the largest market share of around 57% in 2021.
This statistic suggests that among different product forms in the market, the single-injection cycle segment was the most dominant, holding a market share of approximately 57% in 2021. This indicates that a significant majority of products purchased or consumed in this category were in the form of single-injection cycles. The high market share of this segment suggests that it is a popular and widely-used product form among consumers. It may imply that there is a strong demand for the convenience, effectiveness, or other benefits associated with single-injection cycle products within the market. Overall, this statistic highlights the importance and influence of the single-injection cycle segment in the market landscape in 2021.
In the Asia Pacific region, China is expected to record the highest CAGR of 19.5% over the forecast period.
This statistic indicates that in the Asia Pacific region, China is projected to experience the highest Compound Annual Growth Rate (CAGR) of 19.5% over the specified forecast period. This means that China’s economy or a specific market sector within China is anticipated to grow at an average annual rate of 19.5% during the forecasted timeframe. This high CAGR suggests significant potential for expansion and development in China compared to other countries in the region, making it an attractive market for investment or business opportunities. It also highlights China’s strong economic performance and potential for future growth in the Asia Pacific region.
By application, the dermal fillers sub-segment commanded a 38.5% share of the market in 2021.
This statistic indicates that within the overall market for cosmetic procedures involving dermal fillers, the sub-segment specifically dedicated to dermal fillers had a substantial market share of 38.5% in 2021. This suggests that a significant portion of the market demand for cosmetic procedures focusing on enhancing facial features, reducing wrinkles, and restoring volume was driven by the use of dermal fillers. The popularity and utilization of dermal fillers within this segment could be attributed to factors such as their effectiveness in achieving desired aesthetic outcomes, minimal invasiveness compared to surgical alternatives, and relatively lower cost. As a result, the dermal fillers sub-segment appears to be a key player within the broader cosmetic procedures market, reflecting consumer preferences and trends in the beauty and aesthetics industry.
By 2028, the orthopedic segment is set to reach $649.4 million, being driven primarily by osteoarthritis applications.
The statistic indicates that by the year 2028, the orthopedic segment is projected to achieve a market value of $649.4 million. This growth is expected to be predominantly fueled by applications related to osteoarthritis within the orthopedic industry. The increasing prevalence of osteoarthritis, coupled with advancements in orthopedic treatments and technologies, is anticipated to drive the market expansion in the coming years. This statistic highlights the significant market potential within the orthopedic sector, particularly in addressing medical conditions such as osteoarthritis, and underscores the importance of continued innovation and investment in this field to meet the growing healthcare needs of individuals.
Europe’s market size is projected to reach $665.1 million by 2028, growing at a CAGR of 7.2% during the forecast period.
This statistic states that the market size of Europe is expected to reach $665.1 million by the year 2028, with a Compound Annual Growth Rate (CAGR) of 7.2% over the forecast period. This growth rate indicates the average annual increase in market size over the specified timeframe. A CAGR of 7.2% suggests a relatively healthy growth rate, signifying that the market is expanding steadily. The projected market size provides an estimate of the total value of goods and services exchanged within Europe’s market by 2028, with the growth rate reflecting the expected pace of this expansion.
In Asia Pacific, Japan held the largest market share of over 23.0% in 2021.
The statistic, “In Asia Pacific, Japan held the largest market share of over 23.0% in 2021,” indicates that within the Asia Pacific region, Japan accounted for the highest proportion of market activity compared to other countries or regions. Specifically, Japan’s market share was reported to be over 23.0% in 2021, suggesting that the Japanese market has a significant influence and presence in the region. This statistic highlights Japan’s economic strength, market dominance, and potentially its competitive advantage in various industries within Asia Pacific during the stated year.
According to the report, five-injection cycles form of hyaluronic acid observed a significant growth rate of 9.5% from 2020 to 2021.
The statistic stated indicates that the form of hyaluronic acid administered through five-injection cycles experienced a notable growth rate of 9.5% between the years 2020 and 2021. This growth rate signifies a considerable increase in the utilization and popularity of this specific form of treatment. The rise could be attributed to various factors such as increased awareness and acceptance of hyaluronic acid injections for various conditions, improvements in the technology and effectiveness of the injections, and potentially shifting trends in healthcare preferences towards non-invasive procedures. This statistic highlights a positive trend in the adoption of hyaluronic acid injections and suggests a growing interest in this particular form of treatment among individuals seeking medical or cosmetic benefits.
Key companies that dominate the market include Allergan, Anika Therapeutics Inc., and Fidia Farmaceutici Spa, which together accounted for over 55% of the market in 2021.
This statistic highlights the market dominance of certain key companies in a specific industry, specifically Allergan, Anika Therapeutics Inc., and Fidia Farmaceutici Spa, which collectively held a significant market share of over 55% in 2021. This indicates that these companies play a pivotal role in shaping the market dynamics and competition within the industry, potentially exerting a strong influence on pricing, innovation, and overall market trends. Their prominence suggests they are likely key players in driving industry performance and trends, showcasing the importance of understanding and monitoring their activities for stakeholders within the market.
In terms of revenue, the cosmetic skin care segment will expand at a CAGR of 6.4% over the forecast period.
This statistic indicates that the cosmetic skin care segment is projected to experience a Compound Annual Growth Rate (CAGR) of 6.4% in terms of revenue over the forecast period, suggesting a steady and consistent growth trend. The CAGR of 6.4% implies that the revenue generated by the cosmetic skin care segment is expected to increase by an average of 6.4% annually throughout the forecast period. This growth rate signifies a promising outlook for the cosmetic skin care industry, suggesting increasing demand and potential opportunities for businesses operating within this segment.
A trend in the market is the increased use of hyaluronic acid for wound healing, which is expected to reach $102.3 million by 2028.
This statistic highlights a growing trend in the market where there is a rising utilization of hyaluronic acid for the purpose of wound healing. The data projects that the market value associated with this trend is anticipated to reach $102.3 million by the year 2028. This suggests a significant increase in the adoption and demand for hyaluronic acid in wound healing applications in the coming years. The statistic implies that stakeholders in the healthcare industry, such as medical professionals, researchers, and pharmaceutical companies, are recognizing the benefits and effectiveness of hyaluronic acid in promoting wound healing, leading to a substantial market growth potential in this specific product segment.
The market value in Latin America is projected to reach $103.5 million by 2028, with Brazil leading in terms of annual growth.
The statistic indicates that the total market value in Latin America is forecasted to grow to $103.5 million by the year 2028. This suggests that the economic size of the market is expected to increase significantly over the next few years. Moreover, the statement highlights that Brazil is set to lead this growth trajectory, implying that the Brazilian market is expected to expand at a faster pace compared to other countries in the region. This may be driven by various factors such as favorable government policies, increasing consumer demand, or advancements in technology. By focusing on Brazil’s performance, it suggests the country’s potential to be a key player in shaping the overall market landscape in Latin America.
In the Middle East and Africa region, South Africa dominated the market with a 32% share in 2021.
The statistic “In the Middle East and Africa region, South Africa dominated the market with a 32% share in 2021” indicates that South Africa had the largest market share compared to other countries in the region during the year 2021. This means that out of all the countries in the Middle East and Africa region, South Africa accounted for 32% of the total market activity or sales. This dominance can reflect various factors such as economic strength, market competitiveness, industry leadership, and consumer demand within South Africa. It also implies that South Africa played a significant role in shaping the market dynamics and performance within the region during the specified period.
The use of hyaluronic acid in anti-aging treatment is estimated to expand at a CAGR of 7.8%, hitting a market value of $87 million by 2028.
The statistic regarding the use of hyaluronic acid in anti-aging treatment predicts a continuous expansion at a compound annual growth rate (CAGR) of 7.8%. This suggests a steady increase in the adoption of hyaluronic acid in anti-aging products and procedures over the forecast period. By the year 2028, the market value for hyaluronic acid in anti-aging treatment is projected to reach $87 million, indicating significant growth and demand within the industry. This trend is reflective of the increasing consumer interest in anti-aging solutions and the effectiveness of hyaluronic acid as a popular ingredient known for its hydrating and skin-rejuvenating properties.
The Veterinary Medicine sector envision to reach $29.4 Million by 2028 in Hyaluronic Acid market.
The statistic states that the Veterinary Medicine sector is projected to achieve a market value of $29.4 million by the year 2028 specifically in the Hyaluronic Acid market. This suggests a growing demand and potential growth in the use of Hyaluronic Acid within the veterinary industry. The figure highlights the economic opportunities and potential investment prospects within this sector, indicating a positive outlook for the industry’s future financial performance in the coming years.
The cosmetic industry’s expenditure on hyaluronic acid in Asia Pacific reached $185 million in 2021.
The statistic indicates that the cosmetic industry in the Asia Pacific region spent a total of $185 million on hyaluronic acid in the year 2021. Hyaluronic acid is a popular ingredient in skincare products due to its ability to retain moisture and improve skin hydration. The significant expenditure on hyaluronic acid reflects the growing demand for skincare and beauty products in the region, as well as the increasing awareness and adoption of skincare routines. This statistic highlights the importance of hyaluronic acid in the cosmetic industry and signifies a lucrative market for companies producing and selling skincare products in the Asia Pacific region.
Despite the COVID-19 pandemic, the industry still managed to grow by 7.5% in 2020.
The statistic ‘Despite the COVID-19 pandemic, the industry still managed to grow by 7.5% in 2020’ indicates that despite facing challenges due to the global pandemic, the industry experienced a growth rate of 7.5% over the course of the year. This growth can be seen as impressive considering the widespread disruptions and economic downturn caused by the pandemic, suggesting resilience and adaptability within the industry. The positive growth rate may be attributed to factors such as increased demand for certain products or services, innovations in business practices, or successful implementation of contingency plans. Overall, this statistic highlights the industry’s ability to thrive and overcome obstacles even in the face of unprecedented challenges.
The market for hyaluronic acid in India is expected to grow by 14% CAGR from 2022 to 2028.
This statistic indicates that the market for hyaluronic acid in India is projected to experience a Compound Annual Growth Rate (CAGR) of 14% over the period from 2022 to 2028. This implies a steady and consistent increase in the market size for hyaluronic acid products in India each year. The CAGR of 14% suggests a significant growth potential for the market, driven by factors such as increasing consumer demand, advancements in technology, expanding applications of hyaluronic acid in various industries, and possibly favorable government policies or regulatory changes. This growth forecast can be crucial for companies operating in the hyaluronic acid market in India, as it highlights the potential opportunities and challenges they may face in the coming years.
Conclusion
Overall, the statistics presented on the Hyaluronic Acid industry highlight its steady growth and significant impact in various sectors such as skincare, pharmaceuticals, and healthcare. These numbers reflect a promising future for the industry, indicating a rising demand and continued innovation in product development. Keep an eye on this versatile compound as it continues to play a crucial role in shaping the market landscape.
References
0. – https://www.www.grandviewresearch.com
